These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10476720)

  • 1. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals.
    Fridkin SK; Steward CD; Edwards JR; Pryor ER; McGowan JE; Archibald LK; Gaynes RP; Tenover FC
    Clin Infect Dis; 1999 Aug; 29(2):245-52. PubMed ID: 10476720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: A report from the National Nosocomial Infections Surveillance (NNIS) System.
    Am J Infect Control; 1999 Jun; 27(3):279-84. PubMed ID: 10358233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial use and susceptibility rates in isolates from intensive care unit and other nosocomial inpatient and outpatient areas.
    Lang A; De Fina G; Meyer R; Aschbacher R; Zelger P; Paluselli P; Rizza F
    New Microbiol; 2001 Jan; 24(1):47-56. PubMed ID: 11209842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance in the intensive care unit: impact of new patterns.
    McGowan J; Tenover F
    Int J Clin Pract Suppl; 1998 Jun; 95():14-22. PubMed ID: 9796551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
    Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
    J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does antimicrobial resistance cluster in individual hospitals?
    McGowan JE; Hill HA; Volkova NV; Lawton RM; Haber MJ; Tenover FC; Gaynes RP;
    J Infect Dis; 2002 Nov; 186(9):1362-5. PubMed ID: 12402210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4606-10. PubMed ID: 15561832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance in the intensive care unit: mechanisms, epidemiology, and management of specific resistant pathogens.
    Fraimow HS; Tsigrelis C
    Crit Care Clin; 2011 Jan; 27(1):163-205. PubMed ID: 21144992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals.
    Fridkin SK; Hill HA; Volkova NV; Edwards JR; Lawton RM; Gaynes RP; McGowan JE;
    Emerg Infect Dis; 2002 Jul; 8(7):697-701. PubMed ID: 12095437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.
    Flamm RK; Weaver MK; Thornsberry C; Jones ME; Karlowsky JA; Sahm DF
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2431-6. PubMed ID: 15215091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
    Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
    J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide surveillance of antimicrobial resistance among non-fermentative Gram-negative bacteria in Intensive Care Units in Taiwan: SMART programme data 2005.
    Jean SS; Hsueh PR; Lee WS; Chang HT; Chou MY; Chen IS; Wang JH; Lin CF; Shyr JM; Ko WC; Wu JJ; Liu YC; Huang WK; Teng LJ; Liu CY
    Int J Antimicrob Agents; 2009 Mar; 33(3):266-71. PubMed ID: 19091522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
    Mutnick AH; Rhomberg PR; Sader HS; Jones RN
    J Antimicrob Chemother; 2004 Feb; 53(2):290-6. PubMed ID: 14711839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals.
    Monnet DL; Archibald LK; Phillips L; Tenover FC; McGowan JE; Gaynes RP
    Infect Control Hosp Epidemiol; 1998 Jun; 19(6):388-94. PubMed ID: 9669619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance trends and outbreak frequency in United States hospitals.
    Diekema DJ; BootsMiller BJ; Vaughn TE; Woolson RF; Yankey JW; Ernst EJ; Flach SD; Ward MM; Franciscus CL; Pfaller MA; Doebbeling BN
    Clin Infect Dis; 2004 Jan; 38(1):78-85. PubMed ID: 14679451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
    J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram.
    Cook PP; Catrou PG; Christie JD; Young PD; Polk RE
    J Antimicrob Chemother; 2004 May; 53(5):853-9. PubMed ID: 15044426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.